Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors

BACKGROUND: Obesity, mainly visceral obesity, and metabolic syndrome (MetS) are major risk factors for the development of type 2 diabetes, cardiovascular diseases, and cancer. Data analyzing the association of obesity and MetS with gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) are lackin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Barrea, Luigi, Muscogiuri, Giovanna, Modica, Roberta, Altieri, Barbara, Pugliese, Gabriella, Minotta, Roberto, Faggiano, Antongiulio, Colao, Annamaria, Savastano, Silvia
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018238/
https://ncbi.nlm.nih.gov/pubmed/33815296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.649496
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares